|
Medication in 114 patients with type 2 diabetes mellitus. |
|||
| Therapy |
Diabetes |
Hypertension |
Lipid-lowering |
|
|
|||
| patients n (%) 114 (100) |
patients n (%) 88 (77.2) |
patients n (%) 28 (24.6) |
|
|
|
|||
| Medications |
|||
| diet |
114 (100) |
||
| sulfonylureas |
29 (25.4) |
||
| metformin |
44 (38.6) |
||
| glitazones |
2 (1.8) |
||
| glinides |
7 (6.1) |
||
| carboanhydrase inhibitors |
2 (1.8) |
||
| insulin (alone/combined) |
52 (45.6) |
||
| statins/fibric acid |
28 (24.6) |
||
| ACE inhibitors |
40 (35.1) |
||
| calcium-channel blockers |
19 (16.7) |
||
| diuretic drugs |
41 (36.0) |
||
| beta-blockers |
32 (28.1) |
||
| others |
3 (2.6) |
||
|
Since combined therapies are possible, percentages/numbers might exceed 100 | |||
Schäffler et al. Cardiovascular Diabetology 2007 6:3 doi:10.1186/1475-2840-6-3 |
|||